PharmaShots | Incisive News in 3 Shots

Subscribe Now

GC Biopharma

GC Biopharma Receives the US FDA Approval for Alyglo (GC5107B),10% Liquid for the treatment of Primary Humoral Immunodeficiency (PI)

GC Biopharma Receives the US FDA Approval for Alyglo (GC5107B),10% Liquid for the treatment of Primary Humoral Immunodeficiency (P...

December 18, 2023

GC Biopharma's GC1126A Receives the US FDA’s Orphan Drug Designation for Thrombotic Thrombocytopenic Purpura

GC Biopharma's GC1126A Receives the US FDA’s Orphan Drug Designation for Thrombotic Thrombocytopenic Purpura

October 6, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us